|Bid||172.67 x 800|
|Ask||172.70 x 1000|
|Day's Range||172.23 - 173.65|
|52 Week Range||137.70 - 179.84|
|PE Ratio (TTM)||64.64|
|Earnings Date||Jul 24, 2018|
|Forward Dividend & Yield||1.88 (1.08%)|
|1y Target Est||181.91|
On Friday, July 13, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. Six out of nine sectors ended Friday's trading session in bullish territories. Taking into consideration last Friday's market sentiment, WallStEquities.com assessed the following Medical Appliances & Equipment equities this morning: Nevro Corp. (NYSE: NVRO), NovoCure Ltd (NASDAQ: NVCR), NuVasive Inc. (NASDAQ: NUVA), and Stryker Corp. (NYSE: SYK).
The acquisition of TVA Medical will enable Becton, Dickinson (BDX) to treat patients with chronic kidney disease through minimally invasive procedures.
Boston Scientific's (BSX) agreement for Cryterion Medical buyout in the field of atrial fibrillation buoys investor optimism on the stock.
MARKET PULSE Medical-tech company Stryker Corp. (syk) said Tuesday it has named Timothy Scannell president and chief operating officer, effective Aug. 1. The company is making the change as David Floyd, group president, orthopaedics, is retiring on June 30, 2019.
July 10, 2018 - Stryker Corporation (SYK) announced today that David K. Floyd, Group President, Orthopaedics has notified the Company of his intent to retire on June 30, 2019. Until this date, Mr. Floyd will serve as Group President and Advisor to the CEO and will assist with transitioning his responsibilities to our newly appointed leaders while also contributing to strategic growth projects. Mr. Floyd joined Stryker in 2012 after 25 successful years in the medical technology industry. David has served as a key member of Stryker`s leadership team and enjoyed terrific success leading our Orthopaedics group.
Medtronic (MDT) continues to meaningfully accelerate all its three fundamental growth strategies, namely therapy innovation, globalization and economic value.
Intuitive Surgical's (ISRG) SureForm 60 stapler receives FDA approval; strengthens its profile for minimally invasive surgical solutions.
Here we take a quick look at the major factors that have been plaguing Wright Medical and discuss the prospects that ensure near-term recovery.
Stryker (SYK) and Baxter's (BAX) strong expected growth rates and rising share price make them close contenders in the MedTech industry.